Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination
Top Cited Papers
- 10 May 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 19 (8), 2007-2013
- https://doi.org/10.1111/jth.15362
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 VaccinationThe New England Journal of Medicine, 2021
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 VaccinationThe New England Journal of Medicine, 2021
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 VaccinationThe New England Journal of Medicine, 2021
- Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)Journal of Thrombosis and Haemostasis, 2021
- Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccinationThe Lancet, 2021
- Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccinationThe Lancet, 2021
- Diagnostic accuracy of IgG‐specific versus polyspecific enzyme‐linked immunoassays in heparin‐induced thrombocytopenia: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2017
- Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysisBlood, 2016